Guilford Pharmaceuticals to Announce Second Quarter 2004 Financial Results on Monday, August 9, 2004
19 Julio 2004 - 9:02AM
PR Newswire (US)
Guilford Pharmaceuticals to Announce Second Quarter 2004 Financial
Results on Monday, August 9, 2004 BALTIMORE, July 19
/PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc.
(NASDAQ:GLFD) will announce its second quarter 2004 financial
results on Monday, August 9, 2004 before the opening of the U.S.
financial markets. The company will also host a conference call and
live audio webcast at 10:00 a.m. E.T. following the announcement.
During this call, Guilford's management will discuss the financial
results and other business for the upcoming year. The press release
and live webcast can be accessed by going to the Investor Relations
section of Guilford's website at http://www.guilfordpharm.com/.
Following the webcast, an archived version of the call will be
available until Monday, August 16, 2004. To participate in the live
conference call, U.S. residents should dial 800-901-5241,
international callers 617-786-2963. The participant passcode is
66836765. An audio replay of the conference call will be available
for 72 hours beginning at approximately 1:00 p.m. E.T. on August 9,
2004 through 1:00 p.m. August 12, 2004. To access the replay, U.S.
residents should dial 888-286- 8010, (int'l callers 617-801-6888),
passcode 19740997. Guilford Pharmaceuticals Inc. is a
pharmaceutical company engaged in the research, development and
commercialization of products that target the hospital market.
Presently, Guilford markets two commercial products, GLIADEL(R)
Wafer (polifeprosan 20 with carmustine implant), for the treatment
of brain cancer, and AGGRASTAT(R) Injection (tirofiban
hydrochloride), a glycoprotein GP IIb/IIIa receptor antagonist used
for the treatment of acute coronary syndrome (ACS). Guilford's
product pipeline includes a novel anesthetic, AQUAVAN(R) Injection.
For additional information about GLIADEL(R) Wafer, please visit
http://www.gliadel.com/; and for AGGRASTAT(R) Injection, please see
http://www.aggrastat.com/. Contact: Guilford Pharmaceuticals Inc.
Stacey Jurchison 410.631.5022 DATASOURCE: Guilford Pharmaceuticals
Inc. CONTACT: Stacey Jurchison, Guilford Pharmaceuticals Inc.,
+1-410-631-5022, Web site: http://www.guilfordpharm.com/ Company
News On-Call: http://www.prnewswire.com/comp/112882.html
Copyright
Guilford (NASDAQ:GLFD)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Guilford (NASDAQ:GLFD)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
Real-Time news about Guilford Pharmaceuticals (MM) (NASDAQ): 0 recent articles
Más de Guilford Pharmaceuticals (MM) Artículos de Noticias